Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies to integrin AVB6 and use of same to treat cancer

Antibodies to integrin AVB6 and use of same to treat cancer

US Patent 9493566 · Granted Nov 15, 2016

Estimated economic value: $110,604,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-αVβ6 antibodies and antibody-drug conjugates2025
Anti-AVB6 antibodies and antibody-drug conjugates2023
BCMA antibodies and use of same to treat cancer and immunological disorders2023
BCMA antibodies and use of same to treat cancer and immunological disorders2021
CD33 antibodies and use of same to treat cancer2020
Methods for screening antibodies2017
CD33 antibodies and use of same to treat cancer2017
Detection and treatment of pancreatic, ovarian and other cancers2015
Epiligrin, an epithelial ligand for integrins2000